LACTOSE (INDIA)
Back to Balance Sheet
|
LACTOSE (INDIA) Last 5 Year Total Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹101 Cr | ₹101 Cr | ₹90 Cr | ₹88 Cr | ₹84 Cr |
What is the latest Total Liabilities ratio of LACTOSE (INDIA) ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹101 Cr |
Mar2023 | ₹101 Cr |
Mar2022 | ₹90 Cr |
Mar2021 | ₹88 Cr |
Mar2020 | ₹84 Cr |
How is Total Liabilities of LACTOSE (INDIA) Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹101 Cr | -0.54 | |
Mar2023 | ₹101 Cr | 12.27 | |
Mar2022 | ₹90 Cr | 2.13 | |
Mar2021 | ₹88 Cr | 5.17 | |
Mar2020 | ₹84 Cr | - |
Compare Total Liabilities of peers of LACTOSE (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LACTOSE (INDIA) | ₹151.2 Cr | 1.9% | -6.6% | -34.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,560.0 Cr | 2.1% | 2.4% | -11.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,033.0 Cr | 0.7% | 8.2% | 8.1% | Stock Analytics | |
CIPLA | ₹134,400.0 Cr | 5.6% | 3.9% | 1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,507.0 Cr | 1.5% | 0.1% | 1.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,628.0 Cr | 3.7% | -3% | -6.4% | Stock Analytics |
LACTOSE (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LACTOSE (INDIA) | 1.9% |
-6.6% |
-34.2% |
SENSEX | 2.9% |
1.7% |
3.6% |
You may also like the below Video Courses